Biogen Idec Q3 total revenues boost 32 percent to $1.8 billion Biogen Idec Inc for a long time . today reported third one fourth 2013 total revenues of $1.8 billion, a rise of 32 percent over the 3rd quarter of 2012. Non-GAAP diluted EPS for the 3rd one fourth of 2013 were $2.35, a rise of 23 percent over the 3rd quarter of 2012. Non-GAAP net gain due to Biogen Idec for the 3rd one fourth of 2013 was $561 million, a rise of 23 percent versus the 3rd one fourth of 2012. GAAP diluted EPS for the 3rd one fourth of 2013 were $2.05, a rise of 23 percent over the 3rd quarter of 2012. GAAP net gain for the third one fourth of 2013 was $488 million, a rise of 22 percent over the 3rd one fourth of 2012.
BioStack 4's unique plate carrier provides fast plate exchange speeds of significantly less than ten mere seconds to improve throughput and enhance efficiency. Related StoriesImproved outcomes yielded from fresh ChIP-seq protocolUsing deep understanding how to evaluate genetic mutations: an interview with Brendan FreyLinkam phases used in the Wolfson Bioimaging Service at the University of Bristol within the endocytic sorting analysis of Dr Paul Verkade BioStack 4 works with with 24 – to 1536-well lidded and low-quantity microplates up to 22 mm high, and interchangeable 10-, 30 – or 50-plate stacks are for sale to individual throughput requirements. The tiny footprint allows procedure within a biosafety enclosure, and conserves important space on the benchtop. Additionally, an optional barcode scanner raises workflow performance while limiting potential consumer errors.